Literature DB >> 7026083

Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.

J L Romson, D W Haack, G D Abrams, B R Lucchesi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7026083     DOI： 10.1161/01.cir.64.5.906

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  In vivo interaction of prostacyclin with an inhibitor of cyclic nucleotide phosphodiesterase, HL 725.

Authors:  H Darius; A M Lefer; I Leprán; J B Smith
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

2.  Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog.

Authors:  P A Martorana; B Kettenbach; H Göbel; R E Nitz
Journal:  Basic Res Cardiol       Date:  1984 Sep-Oct       Impact factor: 17.165

3.  Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.

Authors:  V B Fiedler; M Mardin
Journal:  Basic Res Cardiol       Date:  1986 Jan-Feb       Impact factor: 17.165

4.  The effects of oral nafazatrom (= BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia.

Authors:  V B Fiedler
Journal:  Basic Res Cardiol       Date:  1983 May-Jun       Impact factor: 17.165

5.  Thrombolytic effects of intracoronary streptokinase on canine coronary artery thrombosis.

Authors:  V B Fiedler
Journal:  Basic Res Cardiol       Date:  1984 Jan-Feb       Impact factor: 17.165

6.  A novel model for evaluating thrombolytic therapy in dogs with ST-elevation myocardial infarction.

Authors:  Hong Zhang; Yong-Chun Cui; Yi Tian; Wei-Min Yuan; Jian-Zhong Yang; Peng Peng; Kai Li; Xiao-Peng Liu; Dong Zhang; Ai-Li Wu; Zhou Zhou; Yue Tang
Journal:  BMC Cardiovasc Disord       Date:  2016-01-25       Impact factor: 2.298
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.